View in EDS HTML Full Text PDF Full Text

GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.

Saved in:
Bibliographic Details
Title: GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.
Authors: Zuberbier, Torsten1,2 (AUTHOR) torsten.zuberbier@charite.de, Muraro, Antonella3 (AUTHOR), Nurmatov, Ulugbek4 (AUTHOR), Arasi, Stefania5 (AUTHOR), Stevanovic, Katarina1,2 (AUTHOR), Anagnostou, Aikaterini6 (AUTHOR), Bonaguro, Roberta3 (AUTHOR), Chinthrajah, Sharon7 (AUTHOR), Lack, Gideon8,9,10 (AUTHOR), Fiocchi, Alessandro5 (AUTHOR), Le, Thuy‐My11,12 (AUTHOR), Turner, Paul13 (AUTHOR), Lozano, Montserrat Alvaro14,15,16 (AUTHOR), Angier, Elizabeth17 (AUTHOR), Barni, Simona18 (AUTHOR), Bégin, Phillippe19,20 (AUTHOR), Ballmer‐Weber, Barbara21,22 (AUTHOR), Cardona, Victoria23 (AUTHOR), Bindslev‐Jensen, Carsten24 (AUTHOR), Cianferoni, Antonella25 (AUTHOR)
Source: Clinical & Translational Allergy. Nov2024, Vol. 14 Issue 11, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457022
DOI:10.1002/clt2.70002